Author Login IJIRT Partner Network (IPN) Login

EVALUATING DRUG SAFETY IN THE ERA OF COVID-19: A REVIEW OF PHARMACOVIGILANCE PRACTICES

  • Unique Paper ID: 157684
  • Volume: 9
  • Issue: 7
  • PageNo: 752-759
  • Abstract:
  • The COVID-19 pandemic has led to the rapid development and widespread use of various medications to treat and prevent the virus. As with any new drug, it is important to carefully assess the safety and effectiveness of the treatments. This review aims to examine pharmacovigilance practices for evaluating drug safety in the context of COVID-19. We begin by defining pharmacovigilance, its functions and importance during the pandemic era. This report also discusses about various types of data sources used in pharmacovigilance, including spontaneous reporting systems, clinical trials, and observational studies. Finally, conclude with the challenges and limitations of pharmacovigilance during the COVID-19 pandemic and suggested strategies for improving drug safety monitoring in this rapidly evolving situation. Overall, this article highlights the crucial role of pharmacovigilance in ensuring safe and effective use of medications in the fight against COVID-19.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 7
  • PageNo: 752-759

EVALUATING DRUG SAFETY IN THE ERA OF COVID-19: A REVIEW OF PHARMACOVIGILANCE PRACTICES

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry